Effects of bisphosphonate on the release of MMP-2 from cultured human osteoblasts

Y Ichinose1, K Migita, T Nakashima

  • 1The First Department of Internal Medicine, Nagasaki University School of Medicine, Japan.

Insights

Bisphosphonates do not affect matrix metalloproteinase-2 (MMP-2) production alone. However, they reduce MMP-2 levels and induce its degradation in the presence of plasmin, suggesting a novel mechanism for inhibiting bone resorption.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Bone Biology

Background:

  • Matrix metalloproteinases (MMPs) play a crucial role in bone resorption.
  • Bisphosphonates are potent inhibitors of bone resorption widely used in treating bone diseases.
  • The precise molecular mechanisms by which bisphosphonates exert their effects are still under investigation.

Purpose of the Study:

  • To investigate the effect of bisphosphonates on the production of matrix metalloproteinase-2 (MMP-2) by human osteoblasts.
  • To determine if bisphosphonates modulate MMP-2 activity or stability in the presence of plasmin.

Main Methods:

  • Human osteoblasts were cultured and treated with bisphosphonates.
  • Conditioned media were analyzed for MMP-2 levels using biochemical assays.
  • The interaction between bisphosphonates, MMP-2, and plasmin was investigated.

Main Results:

  • Bisphosphonates alone did not alter the production of MMP-2 by osteoblasts.
  • In the presence of physiological concentrations of plasmin, bisphosphonates significantly reduced MMP-2 levels in osteoblast-conditioned media.
  • Bisphosphonate treatment promoted the degradation of MMP-2 when plasmin was present.

Conclusions:

  • Bisphosphonates, acting as divalent cation chelators, negatively regulate the stability of MMP-2 in a plasmin-containing environment.
  • These findings suggest that bisphosphonates may inhibit bone resorption by preventing plasmin-mediated protection and subsequent degradation of MMP-2.